Sulodexide / Tinn Cancer Research Results

Sul, Sulodexide: Click to Expand ⟱

Features:

Natural-origin glycosaminoglycan pharmaceutical composed primarily of a fast-moving heparin/heparan-sulfate-like fraction (~80%) and dermatan sulfate (~20%). It has antithrombotic, profibrinolytic, endothelial-protective, glycocalyx-protective, anti-inflammatory, and microcirculatory effects. Sulodexide has also been studied clinically for chronic subjective tinnitus, possibly through improvement of cochlear microvascular/endothelial function. It is generally classified as a drug rather than a conventional dietary supplement.

Tinn, tinnitus: Click to Expand ⟱

Source:

Type:

tinnitus

Scientific Papers found: Click to Expand⟱

7494-

MEL,

Sul,

Medical and surgical treatments for tinnitus: the efficacy of combined treatment with sulodexide and melatonin

Trial,

Nor,

30 patients with tinnitus were treated with sulodexide (250 LSU BID, in the morning and in the evening) and melatonin (3 mg in the evening before going to sleep) for 80 days.

*Dose↝, *Tinn↓, *AntiThr↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Total Targets: 0

Pathway results for Effect on Normal Cells:

NA, unassigned(tgid=0) ⓘ

Tinn↓, 1,

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 1,
Total Targets: 3

Scientific Paper Hit Count for: Tinn, tinnitus

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells